Your browser doesn't support javascript.
loading
Long-term cohort study of patients presenting with hypercapnic respiratory failure.
Chung, Yewon; Garden, Frances L; Marks, Guy B; Vedam, Hima.
Affiliation
  • Chung Y; School of Clinical Medicine, South Western Sydney Clinical Campuses, Discipline of Medicine, UNSW Sydney, Sydney, New South Wales, Australia yewon.chung@health.nsw.gov.au.
  • Garden FL; Department of Respiratory and Sleep Medicine, Liverpool Hospital, Sydney, New South Wales, Australia.
  • Marks GB; Ingham Institute for Applied Medical Research, Sydney, New South Wales, Australia.
  • Vedam H; School of Clinical Medicine, South Western Sydney Clinical Campuses, Discipline of Medicine, UNSW Sydney, Sydney, New South Wales, Australia.
BMJ Open Respir Res ; 11(1)2024 Jul 20.
Article in En | MEDLINE | ID: mdl-39032938
ABSTRACT

OBJECTIVE:

We sought to describe the long-term prognosis for a population-based cohort of people with hypercapnic respiratory failure (HRF) and the associations between underlying diagnoses and the risks of death and rehospitalisation.

METHODS:

We performed a historical cohort study of all persons with HRF in the Liverpool local government area in New South Wales, Australia, in the 3-year period from 2013 to 2015. Cohort members were identified using arterial blood gas results from Liverpool Hospital demonstrating pH ≤7.45 and PaCO2 >45 mm Hg within 24 hours of presentation. Linked health data were obtained from statewide registries with a minimum follow-up period of 6 years. The primary outcomes were time to death from any cause and the standardised mortality ratio (SMR) which compares the observed to the expected number of deaths in the same population. Secondary outcomes were time to rehospitalisation and the associations between death and/or hospitalisation and underlying diagnoses.

RESULTS:

The cohort comprised 590 adults aged between 15 and 101 years. Overall, 415 (70.3%) participants died in the follow-up period. Among those who survived the index admission, the probability of survival at 1, 3 and 5 years was 81%, 59% and 45%, respectively. The overall SMR was 9.2 (95% CI 7.6 to 11.0), indicating a near 10-fold risk of death than otherwise expected for age. Most (91%) survivors experienced rehospitalisation, with median (IQR) time to readmission of 3.9 (1.2-10.6) months. Congestive cardiac failure and neuromuscular disease were associated with an increased risk of death, whereas chronic obstructive pulmonary disease and sleep disordered breathing increased the risk of rehospitalisation.

CONCLUSIONS:

HRF is associated with poor survival and high risk of rehospitalisation in the 5 years following an index event. The underlying disease appears to have some influence on overall survival and subsequent hospitalisations.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Patient Readmission / Respiratory Insufficiency / Hypercapnia Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Oceania Language: En Journal: BMJ Open Respir Res Year: 2024 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Patient Readmission / Respiratory Insufficiency / Hypercapnia Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Oceania Language: En Journal: BMJ Open Respir Res Year: 2024 Document type: Article Affiliation country: Country of publication: